Acorda Therapeutics Inc PEG
What is the PEG of Acorda Therapeutics Inc?
The PEG of Acorda Therapeutics Inc is N/A
What is the definition of PEG?
Price/earnings to growth (PEG) ratio is a stock’s P/E ratio divided by a predicted growth rate of its earnings for a time period of 5 years.
= forward PE / 5-year EPS growth rate
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with peg similar to Acorda Therapeutics Inc
- Mallinckrodt Plc has PEG of N/A
- HighPoint Resources Corp has PEG of N/A
- Adamas Pharmaceuticals Inc has PEG of N/A
- Pivot Technology Solutions has PEG of N/A
- Copper Mountain Mining has PEG of N/A
- SITO Mobile has PEG of N/A
- Acorda Therapeutics Inc has PEG of N/A
- RumbleON Inc has PEG of N/A
- Endologix has PEG of N/A
- Alto Ingredients Inc has PEG of N/A
- Sunesis Pharmaceuticals Inc has PEG of N/A
- Unit has PEG of N/A
- Pacific Drilling SA has PEG of N/A